You are here Home Resources and guidance Sponsors Pharming Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Designation or determination (2) ARTG (1) Date 2025 (3) Search Sponsor content3 result(s) found, displaying 1 to 3 Notice for leniolisib (Pharming Australia Pty Ltd) 24 October 2025 Designation or determination Orphan Drug Notice for leniolisib (Pharming Australia Pty Ltd) 24 October 2025 Designation or determination Priority review JOENJA leniolisib (as phosphate) 70 mg film coated tablets bottle (416199) 18 March 2025 ARTG Australian Register of Therapeutic Goods (ARTG) information for JOENJA leniolisib (as phosphate) 70 mg film coated tablets bottle.
Notice for leniolisib (Pharming Australia Pty Ltd) 24 October 2025 Designation or determination Orphan Drug
Notice for leniolisib (Pharming Australia Pty Ltd) 24 October 2025 Designation or determination Priority review
JOENJA leniolisib (as phosphate) 70 mg film coated tablets bottle (416199) 18 March 2025 ARTG Australian Register of Therapeutic Goods (ARTG) information for JOENJA leniolisib (as phosphate) 70 mg film coated tablets bottle.